BiotechTube
Home/Pipeline/Aβ1-40/Aβ1-42/Tau IMR Reagents

Aβ1-40/Aβ1-42/Tau IMR Reagents

Alzheimer's Disease Diagnosis

CommercialActive

Key Facts

Indication
Alzheimer's Disease Diagnosis
Phase
Commercial
Status
Active
Company
MagQu

About MagQu

MagQu is a diagnostics company built on its patented ImmunoMagnetic Reduction (IMR) technology, which enables picoscale, highly sensitive detection of biomarkers in blood. Its core focus is on developing and commercializing assays for Alzheimer's disease (detecting Aβ-40, Aβ-42, and Tau proteins) and cancers like liver and colorectal cancer. The company is commercial-stage, with ISO and GMP certifications, TFDA approvals for its analyzers, and a growing international sales footprint across Asia, Europe, and the US.

View full company profile

Therapeutic Areas

Alzheimer's DiseaseNeurological DisordersLiver CancerColorectal Cancer

Other Alzheimer's Disease Diagnosis Drugs

DrugCompanyPhase
iRS-ADBetaSenseResearch/Development
Afina Retinal ImagingNeuroVision ImagingValidation/Development
Alzheimer's BiomarkerAelan Cell TechnologiesTest Stage
Oligomer Diagnostic BiomarkersAbyssinia BiologicsPreclinical/Research
ABtest-ServiceAraclon BiotechCommercial
AlzTEST®Neuron BiopharmaNot Specified